Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 10 Nov 2022 for Prostatype genomics, €1,825.
Filing timeline
BuySaleMichael Häggman
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael Häggman: trading record in brief
Our data holds just one disclosure by Michael Häggman, dated 10 November 2022, reporting an open-market purchase worth €1,825 in Prostatype genomics. Further filings will be added here. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael Häggman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 10,000 shares@ SEK 1.99100.0% of flowAktieFI:csv-d64cf62337b207b6d101Canonical exit: 8 Feb 2023 (T+90)
1 of 1 declaration